435 Pegasus HNSCC, a platform study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL-2) with anti-cancer agents in patients with recurrent/metastatic head and neck squamous cell carcinoma
oleh: Myung Ju Ahn, Lisa Licitra, Caroline Even, Chia-Jui Yen, George Blumenschein, Robin Meng, Giovanni Abbadessa, Fatima-Zohra Menas, Miao Zang
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.